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Eleusine indica Linn. Gaerth or Indian goose grass has been widely used as an alternative natural
anti-hypertensive agent. However, the rationale behind this mechanism is still unknown. The
purpose of this study is to confirm the presence of functional groups that may be responsible for its
ACE inhibitory activity and its possible synergism. Each solvent-portioned fraction was analyzed
by FTIR, individual ACE inhibitory activity, and combination of fractions. FTIR results of solventpartitioned fractions revealed that O-H and C-H stretches were present in all fractions. In addition
to this, C-O and C=O groups were also present in all fractions except in ethyl acetate. S=O groups
were also present in chloroform, ethyl acetate, and n-butanol fractions. Other function groups
such as N-O and C=C groups were present in ethyl acetate and n-butanol fractions, respectively.
The highest % inhibition obtained among the individual fraction is n-butanol at 96.031 % ± 0.004
at 500 ug/ml. The lowest % inhibition obtained among the individual fraction is chloroform
at 32.544 % ± 0.011 at 500 ug/ml. The highest % inhibition among the combined fractions is
ethyl acetate:butanol at 95.727% ± 20.847, while the lowest % inhibition in combination is
hexane:chloroform at 89.626 % ± 19.577. The fraction with the lowest IC50 is hexane at 15.357,
while the highest IC50 is chloroform at 168.207 ug/ml. Functional group present may be associated
with the antihypertensive activity of the E. indica extracts. The more polar solvent-partitioned
fractions of E. indica has a higher ACE inhibitory activity compared to its less polar solventpartitioned fractions. The higher ACE inhibitory activity may be associated with the secondary
metabolites present in the more polar fractions. There is also possible synergism present in the
combined solvent-partitioned fractions as their % inhibition is higher than their individual effects.
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INTRODUCTION
Eleusine indica or commonly known in the Philippines
as paragis, is a terrestrial plant with a wide distribution
across the world including Asia, Africa, North America,
and parts of Europe due to its wide tolerance to various
environmental conditions. (Cha, et al., 2014). Aside from
this, E. indica is a native plant in tropical and subtropical
regions like the Philippines. Traditionally, its decoction
from the leaves are used to treat asthma, muscle pains,
febrifuge, diarrhea, and dysentery. In addition, E.
indica is used to treat bladder disorders, convulsions
and childbirth aid in other countries. The whole plant
is usually used as a diuretic, laxative, and depurgative
making it useful for the treatment of influenza, oliguria,
and hypertension (Ettebong et al., 2012).
Hypertension is a major risk factor for cardiovascular
diseases that commonly affects adults. Since high blood
pressure is usually asymptomatic in its initial stages, it
has been labelled as a silent killer. It can cause diseases
such as heart failure, kidney failure, and stroke. (Amin

et al, 2013). According to the World Health Organization
(WHO) (2017), the rampant increase of hypertension
cases is associated with population growth, aging
and behavioral risk factors. The Renin-AngiotensinAldosterone-System (RAAS), a powerful arterial blood
pressure regulator, has become a focus on the hunt for
targets in the elimination of hypertension. (Bangalore et
al., 2016). A component of the RAAS is the AngiotensinConverting Enzyme (ACE) which in high levels leads
to increased concentration of angiotensin II causing to
hypertension.
In the study of Hernandez and Tutor (2018), hexane and
ethyl acetate sequential fractions of E. indica showed
lower ACE inhibitory activity compared to the crude
methanolic extract. The researchers attribute the result
to a possible synergism, an activity in which activity is
lost in purified fractions.
In this study, the researchers confirm the presence of
functional groups that may be responsible for its ACE
inhibitory activity.
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METHODS
Chemicals
The ACE kit-WST by Dojindo Molecular Technologies,
Inc. was purchased from Integrated Biolabs, Taiwan.
Plant Sample Preparation
E. indica was collected from the wide grasslands of
San Fernando, Romblon, Philippines as the grass is
abundant and grows all year round. The plant samples
were collected in October 2018. The plant samples were
cleaned with distilled water and were air-dried in shade
for 3 days. It was grinded with a Wiley-mill grinder and
stored in a wide mouthed amber bottle. The samples were
identified and authenticated by Philippine Bureau of
Plant Industry (BPI) and a voucher specimen was made.
Crude Extraction
The extraction was adapted from the study of Hernandez
and Tutor (2018) with a slight modification. Dried
powdered sample of E. indica was soaked in methanol
for 3 days. The sample was collected using a percolator
and was evaporated in a digital water bath at 40oC.
The collected methanolic extract was oven-dried and
weighed. The % yield was calculated using the formula:

Solvent Partition
The solvent partition method was adapted from the
methods of Kupchan (2016) with slight modifications
by adding chloroform into the process. Five g of the
crude methanolic extract was partitioned using hexane,
chloroform, ethyl acetate, and n-butanol to obtain their
fractions. The fractions obtained were evaporated in a
digital hot bath at 50oC. and were dried in an oven at
40oC and weighed.
Fourier Transform Infrared (FTIR) Analysis
The spectra measurement of the crude methanolic extract
and the fractions collected was performed using the
PerkinElmer Spectrum Two FT-IR. A pinch amount of
the dried samples was placed in the universal attenuated
total reflectance (ATR) (Rohman & Che, 2012).
ACE Inhibitory Activity Determination
ACE inhibition assay kit was used to determine the
angiotensin converting enzyme inhibitory activity
from the obtained crude methanolic extract, solventpartitioned fractions of hexane, chloroform, ethyl acetate,
and n-butanol, and its chosen combination.
The working solution was prepared as specified in the
manual included in the kit. A solution containing Enzyme
B was prepared by dissolving the solution with 2 ml of
deionized water. Then, 1.5 ml of the solution was added
E-ISSN 2477-0612
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to Enzyme A to prepare the Enzyme sample. An indicator
working solution was also prepared by dissolving a
solution containing Enzyme C and coenzyme with 3
ml each of deionized water. Afterwards, 2.8 mL of the
solution containing Enzyme C was added to 2.8 ml of
coenzyme solution for the preparation of the indicator
working solution. The sample solution was prepared into
several portions by diluting it with deionized water by
two-fold dilution. Starting concentration was 500 μg/mL
of plant extract.
Twenty μl of sample solution was placed in a well and
a separate two 20 μl of deionized water for blank 1 and
blank 2. Twenty μl of the substrate buffer was placed
on all wells. Twenty μl of deionized water was added
to the well of blank 2. Subsequently, 20 μl of enzyme
solution was added to each sample well and blank 1 well.
The plate was incubated at 37°C for 1 hour. Afterwards,
200 μl of indicator working solution was added to all
wells. In the final step, the solution was incubated at
room temperature for 10 minutes before the absorbance
was read at 450 nm using a microplate reader (Dojindo
Laboratories, 2016).
ACE inhibitory activity was calculated by the following
equation:

IC50
IC50 was determined using Quest Graph™ IC50 Calculator.
The formula used is as follows:

RESULTS AND DISCUSSION
FTIR
The FTIR analysis was performed to identify the
functional groups present in the crude methanolic
extract and various solvent-partitioned fractions of E.
indica. The FTIR spectroscopic analysis showed various
functional groups present in the plant and exists both or
copiously on almost all solvent-partitioned fractions.
The crude methanolic extract (Figure 1) FTIR results
revealed that the O-H (3200-2700 cm-1 and 1420-1330
cm-1), and C-H (3000-2840 cm-1 and 700 ± 20 cm-1)
groups have been detected. In addition, C-O and (12101163 cm-1) and C=O (1710-1680 cm-1) groups were also
detected.
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Figure 1. FTIR spectra of crude methanolic extract

Figure 2. FTIR spectra of hexane-partitioned fraction
The hexane-partitioned fraction (Figure 2) FTIR results
revealed that the O-H (3200-2700 cm-1 and 1420-1330
cm-1), and C-H (3000-2840 cm-1 and 700 cm-1) groups
have been detected. In addition, C-O and (1210-1163 cm1
) and C=O (1710-1680 cm-1) groups were also detected.

cm-1) groups were detected. In addition, C-O and (12101163 cm-1) and C=O (1710-1680 cm-1) groups were also
detected. Notably, S=O (1372-1335 cm-1 and 1070-1030
cm-1) and C=C (1678-1668 cm-1) group were detected as
well.

The chloroform-partitioned fraction (Figure 3) FTIR
results revealed that the O-H (3200-2700 cm-1 and 14201330 cm-1), and C-H (3000-2840 cm-1 and 700 cm-1)
groups have been detected. In addition, C-O and (12101163 cm-1) and C=O (1710-1680 cm-1) groups, and
notably, an S=O functional group, were all present.

The overlaid spectra (Figure 6) showed all individual
solvent-portioned fractions to have the O-H (3200-2700
cm-1 and 1420-1330 cm-1), and C-H (3000-2840 cm-1 and
700 cm-1) functional groups. In addition, C-O and (12101163 cm-1) and C=O (1710-1680 cm-1) groups were also
detected in all solvent-partitioned fractions except for
ethyl acetate. S=O (1372-1335 cm-1 and 1070-1030 cm-1)
groups were detected in chloroform, ethyl acetate, and
n-butanol-partitioned fractions, while N-O (1650-1580
cm-1) functional group and C=C (1678-1668 cm-1) were
detected in ethyl acetate-solvent partitioned fraction and
n-butanol-partitioned fraction, respectively.

The ethyl acetate-partitioned fraction (Figure 4) FTIR
results revealed that the O-H (3200-2700 cm-1 and 14201330 cm-1), and C-H (3000-2840 cm-1 and 700 cm-1)
groups have been detected. Notably, S=O (1372-1335
cm-1 and 1070-1030 cm-1) and N-O (1650-1580 cm-1)
functional groups were detected.
The n-butanol-partitioned fraction (Figure 5) FTIR
results revealed that the O-H (3200-2700 cm-1 and
1420-1330 cm-1), and C-H (3000-2840 cm-1 and 700

The FTIR analysis helps to identify a possible secondary
metabolite that may be present in each fraction based
on their characteristic functional groups. One of the
secondary metabolites that may have exerted ACE
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Figure 3. FTIR spectra of chloroform-partitioned fraction

Figure 4. FTIR spectra of ethyl acetate-partitioned fraction

Figure 5. FTIR Spectra of n-Butanol-Partitioned Fractions
inhibitory activity would be the flavonoids. It is shown
that various flavonoids can inhibit ACE with varying
% inhibition, with luteolin having the highest recorded
% inhibition of 95% (Garcia-vallve, et al., 2012).
Furthermore, Eleusine indica is found to have two
flavonoids called vitexin and isovitexin (Yeligar, 2018).
E-ISSN 2477-0612

We can validate the presence of the flavonoids, since
its characteristic functional groups are O-H, C-O, and
C=O which were revealed by the FTIR, and certain
extracts of Eleusine indica contain flavonoids based on
various phytochemical screening conducted in previous
studies. Although flavonoids are often related to the
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Figure 6. Overlaid FTIR spectra of the solvent-partitioned extracts of E. indica
anti-hypertensive effects in literatures, anti-hypertensive
effects are not necessarily exclusive to it, and other
secondary metabolites may also contribute or exhibit
anti-hypertensive properties.
ACE Inhibitory Activity
The % inhibition of crude methanol extract (Figure 7)
with varying concentrations of 500 ug/ml, 250 ug/ml,
125 ug/ml, and 62.5ug/ml inhibits ACE at 86.919% ±
0.006, 80.108% ± 0.035, 59.179% ± 0.023, 49.346% ±
0.048 respectively. The relationship of the % inhibition
and concentration is dose dependent.

Figure 7. ACE inhibitory activity of crude methanolic
extract of Eleusine indica

The % inhibition of hexane-partitioned fraction (Figure
8-A) with varying concentrations of 500 ug/ml, 250 ug/
ml, 125 ug/ml, and 62.5ug/ml inhibits ACE at 91.926%
± 0.003, 74.222% ± 0.032, 60.352% ± 0.023, 35.769%
± 0.011, respectively. The % inhibition of chloroformpartitioned fraction (Figure 8-B) with varying
concentrations are similar to the previously mentioned
concentrations inhibiting ACE at 90.325% ± 0.011,
72.779% ± 0.035, 51.037% ± 0.112, 32.544% ± 0.182,
respectively. The % inhibition of ethyl acetate-partitioned
fraction (Figure 8-C) with varying concentrations are
similar to the previously mentioned concentrations
inhibiting ACE at 92.309% ± 0.043, 82.206% ± 0.027,
51.624% ± 0.058, 32.815% ± 0.099, respectively. The %
inhibition of n-butanol-partitioned fraction (Figure 8-D)
with varying concentrations are similar to the previously
mentioned concentrations inhibiting ACE at 96.031%
± 0.004, 82.251% ± 0.007, 65.111% ± 0.005, 43.843%
± 0.128, respectively. All solvent fractions exhibited a
dose-depended response.
All concentrations of all solvent-partitioned fractions
ranging from 125-500 ug/ml have significant %
inhibition. N-butanol-partitioned fraction has the highest
% inhibition across most concentrations (500 ug/ml, 250
ug/ml, and 125 ug/ml) having a % inhibition of 96.031%,
82.251%, and 65.111%, respectively, with the exemption
on the lowest concentration in which methanol crude
extract exhibited the highest % inhibition of 43.843%.
On the other hand, the chloroform-partitioned fraction
has the lowest % inhibition across all concentrations (500
ug/ml, 250 ug/ml, 125 ug/ml, and 62.5ug/ml) having a
% inhibition of 90.325%, 74.779%, 51.037%, 32.544%,
respectively. We have observed that the polar fractions
(ethyl acetate and n-butanol fractions) tend to have
E-ISSN 2477-0612
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(b)

(d)
(c)
Figure 8 (a-d). ACE inhibitory activity of solvent partitioned-fractions of Eleusine indica
a higher % inhibition (Tutor & Chichico-Hernandez,
2017). It is possible that the secondary metabolites
such as alkaloids, flavonoids, glycosides, and steroids
found on ethyl acetate and n-butanol fractions may have
probably contributed to its higher % inhibition (Ajiwe,
2015 and Yeligar, 2018).
ACE Inhibitory Activity of Combined SolventPartitioned Fractions
Six combinations of the fractions ethyl acetate: hexane
(EA:H), ethyl acetate:chloroform (EA:C), hexane:
chloroform (H:C), ethyl acetate:-butanol (EA:B),
chloroform:butanol (C:B), and hexane:n-butanol (H:B)
at a concentration of 500 ug/ml were tested. Figure
9 shows the % inhibition per fraction combination.
EA:H shows a % inhibition of 93.009% ± 20.232,
EA:C at 94.204% ± 20.604, H:C at 89.626% ± 19.577,
EA:B at 95.737% ± 20.847, C:B at 93.978% ± 20.477,
and H:B at 93.978% ± 20.604. It is observed that the
combination of the polar fraction EA+B exhibited the
highest % inhibition of 95.737% ± 20.847, and that the
E-ISSN 2477-0612

combination of the non-polar fraction H+C exhibited
the lowest % inhibition of 89.626% ± 19.577. There
might be a possible synergism present in the combined
fractions, since their % inhibition were greater than their
individual effects.
IC50
Figure 10 (a-e) shows the IC50 of the methanol crude
extract and each individual solvent-partitioned fraction.
The IC50 of the methanol crude extract is at 164.318
ug/ml, n-butanol-partitioned fraction at 37.590 ug/
ml, hexane-partitioned fraction at 15.357 ug/ml (the
lowest), chloroform-partitioned fraction at 168.207 ug/
ml (the highest), and ethyl acetate-partitioned fraction at
153.078 ug/ml.
Both hexane and n-butanol-partitioned fraction exhibited
low IC50 compared to other portioned fractions. Both
partitioned fractions have also shown some similar peaks
in FTIR which refers to functional groups such as C-H,
C-O, and C=O.

Pharm Sci Res, Vol 7 No 1, 2020

ACE Inhibitory Activity and Functional Group Analysis

63

Figure 9. ACE inhibitory activity of combined solvent-partitioned fractions of Eleusine indica

(a)

(c)

(b)

(d)

(e)

Figure 10 (a-e). IC50 methanolic crude extracts and solvent-partitioned fractions
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CONCLUSIONS
Functional group present may be associated with the
antihypertensive activity of the E. indica extracts.
Eleusine indica shows significant ACE inhibitory activity
across all fractions at concentrations ranging from 500
ug/ml to 125 ug/ml, since % inhibition exceeds 50%.
Among the individual fractions, n-butanol shows the
highest % inhibition. The more polar solvent-partitioned
fractions of E. indica has a higher ACE inhibitory activity
compared to its less polar solvent-partitioned fractions.
The higher ACE inhibitory activity may be associated
with the secondary metabolites present in the more polar
fractions., while among the combined fractions EA:B
showed the highest % inhibition. There is also possible
synergism present in the combined solvent-partitioned
fractions as their % inhibitions are higher than their
individual effects.
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